Chemical Structure (Image 01)
Chemical structure of the active ingredient Cilostazol, showing its detailed molecular arrangement including rings and bonds.*
Cilostazol
Product Images NDC 68151-3844
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cilostazol (NDC 68151-3844). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure-1.jpg (Image 02)
A line graph showing plasma concentration (ng/mL) versus time (hours) for Cilostazol and its metabolites. The graph includes three lines representing Cilostazol, 3,4-dehydrocilostazol, and 4'-trans-hydroxycilostazol, with measured concentrations decreasing over a 24-hour period.*
Figure 2 (Image 03)
Bar chart depicting percent mean improvement in maximal walking distance across different trial durations for Cilostazol at 50 mg and 100 mg twice daily compared to placebo. The x-axis shows various trial numbers and durations in weeks, with participant numbers labeled. The y-axis represents percent improvement in walking distance.*
Label Image (Lbl681513844)
Packaging label for Cilostazol 50 mg tablets. The label includes manufacturer information indicating the manufacturer as Roxane. It displays the lot number 262994A, expiration date 08/14, and a barcode with the number 0000003844. The label states "RX ONLY" indicating a prescription medication.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
